Skip to main content
Have a personal or library account? Click to login
Eptifibatide-Induced Profound Thrombocytopenia After Percutaneous Intervention for Acute Coronary Syndrome: A Challenging Clinical Scenario Cover

Eptifibatide-Induced Profound Thrombocytopenia After Percutaneous Intervention for Acute Coronary Syndrome: A Challenging Clinical Scenario

Open Access
|Oct 2017

References

  1. Hongo RH Brent BN. Association of eptifibatide and acute profound thrombocytopenia. American J Cardiol. 2001 Aug 15; 88 4: 42831.
  2. Evatt BL. HIV Infection and thrombocytopenia. Curr Hematol Rep. 2005 Mar; 4 2: 14953.
  3. Williamson DR , Albert M , Heels-Ansdell D , .; PROTECT collaborators, the Canadian Critical Care Trials Group, and the Australian and New Zealand Intensive Care Society Clinical Trials Group Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest. 2013 Oct; 144 4: 120715.
  4. Fahdi IE , Saucedo JF , Hennebry T , Ghani M , Sadanandan S , Garza-Arreola L. Incidence and time course of thrombocytopenia with abciximab and eptifibatide in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2004 Feb 15; 93 4: 4535.
  5. Tcheng JE , Kereiakes DJ , Lincoff AM , .; for the ReoPro Readministration Registry Investigators Abciximab readministration: results of the ReoPro Readministration Registry. Circulation. 2001 Aug 21; 104: 8705.
  6. Sloand E. Hematologic complications of HIV infection. AIDS Rev. 2005 Oct–Dec; 7 4: 18796.
  7. Scaradavou A. HIV-related thrombocytopenia. Blood Rev. 2002 Mar; 16 1: 736.
  8. Nardi M , Tomlinson S , Greco MA , Karpatkin S. Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell. 2001 Sep 7; 106 5: 55161.
  9. Bougie DW , Wilker PR , Wuitschick ED , Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood. 2002 Sep 15; 100 6: 20716.
  10. Madan M Berkowitz SD. Understanding thrombocytopenia and antigenicity with glycoprotein IIb–IIIa inhibitors. Am Heart J. 1999 Oct; 138 4 Pt 2: 31726.
  11. Graidis C , Golias C , Dimitriadis D , Eptifibatide–induced acute profound thrombocytopenia: a case report. BMC Res Notes. 2014; 7: 107.
  12. Refaat M , Smith AJ , Edmundowicz D. Eptifibatide-induced thrombocytopenia. J Thromb Thrombolysis. 2008 Apr; 25 2: 2046.
Language: English
Page range: 248 - 252
Published on: Oct 1, 2017
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2017 Nirmanmoh Bhatia, Robert D. Sawyer, Sohail Ikram, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.